Esperion Therapeutics, Inc.
Board Member
2025-07-01–present
Board Member
Esperion Therapeutics, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Craig Thompson is recorded as Board Member at Esperion Therapeutics, Inc.. Esperion Therapeutics, Inc. reported in an 8-K filed July 1, 2025 that Craig Thompson was appointed Class II director, effective July 1, 2025.
“On July 1, 2025, upon the recommendation of the Nominating and Corporate Governance Committee, the Board of Directors (the "Board") of Esperion Therapeutics, Inc. (the "Company") elected Craig Thompson to the Board, effective July 1, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Esperion Therapeutics, Inc.
Board Member
SEC 8-K
2025-07-01–present
Recorded roles and call appearances connecting this person to public companies.
Esperion Therapeutics, Inc.
Board Member
2025-07-01–present
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.